Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

News   Aug 22, 2017 | Original story from UNC Lineberger

 
Mechanism Behind Poor Response to Immunotherapy in Some Cancers Identified

Credit: Jonathan Serody, MD, UNC Lineberger member and the Elizabeth Thomas Professor in the UNC School of Medicine

 
 
 

RELATED ARTICLES

Gene Associated with Schizophrenia Risk May Regulate Neurodevelopment

News

The gene is involved in the translation of proteins from RNA and in the proliferation and migration of neurons in the brain.

READ MORE

Regenerating Tissues with Gene-targeting Molecules

News

Stem cells can be triggered to change into heart muscle cells by a new method involving synthetic molecules.

READ MORE

Generating T Cells With a More Powerful Anti-cancer Effect

News

Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer, show that while one starts off with a bang, the other endures as the more powerful tumor fighter.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE